Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

NKHP to break grain transshipment record in 2024

1/15/25 NKHP

VK prepares Skillbox for IPO

1/15/25 VKCO

Kamaz in 2024 sold 24.5 thousand units of vehicles in 2024

1/15/25 KMAZ

UTair passenger traffic by airplane in 2024 increased by 5.7%

1/15/25 UTAR

Ozon entered the car leasing market

1/15/25 OZON

Fix Price plans to open at least 700 new stores in 2025

1/15/25 FIXP

Positive Technologies has distributed shares to contributors

1/15/25 POSI

VKontakte overtakes YouTube for the first time in terms of monthly reach

1/15/25 VKCO

Lukoil replaces CEO due to US sanctions

1/14/25 LKOH

Aeroflot's passenger traffic in 2024 will grow by 17%

1/14/25 AFLT